Veterinary Infectious Disease Diagnostics Market Size & Forecasts 2026-2035, By Segments (Animal Type, Technology, End User), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Zoetis, IDEXX Laboratories, Heska Corporation, Abaxis (now part of Zoetis), Biogal-Galed Labs)
Market Size and Growoth Outlook
Veterinary Infectious Disease Diagnostics Market size is set to grow from USD 8.29 billion in 2025 to USD 19.99 billion by 2035, reflecting a CAGR greater than 9.2% through 2026-2035. Industry revenues in 2026 are estimated at USD 8.96 billion.
Get more details on this report
Request Free Sample ReportVeterinary Infectious Disease Diagnostics Market Intelligence Snapshot
Regional Market Dynamics
Segment Momentum
Market Expansion Drivers
Leading Market Participants
Global Market Forecast Snapshot
Market Outlook
Regional and Segment Outlook
Market Growth Drivers and Industry Trends
The increasing prevalence of infectious diseases in livestock and companion animals is a significant growth driver for the veterinary infectious disease diagnostics market. Factors such as intensified animal farming, global trade, and climate change have contributed to outbreaks of diseases like African swine fever and avian influenza, as reported by the World Organisation for Animal Health (WOAH). This trend elevates demand for timely, accurate diagnostics to prevent large-scale losses and zoonotic spillovers. Established companies can leverage this by advancing pathogen-specific assays and comprehensive screening services, while new entrants can focus on niche markets or emerging diseases. Given continuing disease emergence and heightened biosecurity policies, diagnostic innovation and capacity expansion remain critical, reinforcing sustained market growth.
Expansion of Veterinary Diagnostic Laboratories
The growth in veterinary diagnostic laboratories—a response to heightened animal health surveillance and regulatory mandates—is fueling the veterinary infectious disease diagnostics market. Government initiatives such as those from the U.S. Department of Agriculture (USDA) have increased funding and accredited lab facilities, improving testing turnaround and geographic coverage. This infrastructure growth facilitates enhanced disease monitoring and outbreak management, enabling companies to scale their service offerings and integrate advanced technologies like molecular diagnostics. For new entrants, partnerships with expanding labs present opportunities for market entry and service diversification. As regulatory frameworks strengthen globally, expanded diagnostic infrastructure will underpin more robust disease control and market evolution.
Growing Adoption of Point-of-Care Diagnostic Solutions
The shift towards rapid, point-of-care diagnostic testing in veterinary practice is transforming the veterinary infectious disease diagnostics market. Portable and user-friendly devices enable veterinarians to perform on-site testing with immediate results, improving treatment decisions and reducing disease spread. Companies like IDEXX Laboratories have driven adoption by commercializing compact platforms that integrate diagnostics with data analytics. This trend meets increasing demand for decentralized, efficient solutions amid rising operational costs and the need for quick disease identification. Strategic opportunities lie in developing multiplex assays and connectivity features. Continued digital advancements and the push for decentralized health management underscore the enduring role of point-of-care diagnostics in this market’s trajectory.
Industry Restraints:
Stringent Regulatory Approval Processes
The veterinary infectious disease diagnostics market is constrained by complex and lengthy regulatory approval processes that vary widely between regions, impeding timely product launches and cross-border scalability. Diverse requirements from agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) demand extensive clinical validation and compliance documentation, increasing operational costs and delaying market entry. This regulatory fragmentation disproportionately burdens smaller firms lacking sufficient compliance resources, while larger companies face higher overheads and time-to-market risks. For example, the FDA’s rigorous vetting of diagnostic tools has been cited by IDEXX Laboratories as a factor extending their development cycles. Moving forward, unless harmonization initiatives by bodies like the World Organisation for Animal Health (WOAH) gain momentum, these procedural intricacies will continue to slow innovation adoption and market expansion, compelling players to invest disproportionately in regulatory expertise and localized product customization.
Limited Awareness and Adoption Among Veterinary Practitioners
A significant restraint stems from limited awareness and adoption of advanced infectious disease diagnostics among veterinary practitioners, particularly in emerging markets and smaller practices. Many veterinarians rely on traditional diagnostic methods due to entrenched habits, cost constraints, or perceived complexity of novel molecular and point-of-care technologies. Reports from the American Veterinary Medical Association (AVMA) highlight that insufficient training and skepticism about new diagnostic accuracy contribute to slow uptake. This hesitancy restricts market growth by dampening demand for innovative products and reducing incentives for companies to expand outreach or invest in education programs. Established companies face barriers in scaling penetration, whereas new entrants struggle to differentiate without practitioner buy-in. Gradual improvement is anticipated as industry stakeholders, including Zoetis and IDEXX Laboratories, increase focus on practitioner education and user-friendly diagnostics; however, widespread adoption will likely remain uneven in the near term.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising incidence of veterinary infectious diseases | 3.00% | Short term (≤ 2 yrs) | North America, Europe; Spillover: Asia Pacific | Low | Fast |
| Expansion of veterinary diagnostic laboratories | 3.00% | Medium term (2–5 yrs) | Asia Pacific, North America; Spillover: Europe | Medium | Moderate |
| Growing adoption of point-of-care diagnostic solutions | 3.20% | Long term (5+ yrs) | Europe, Asia Pacific; Spillover: North America | Low | Moderate |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America dominated the veterinary infectious disease diagnostics market in 2025, accounting for 43.8% of the global share. This leadership stems primarily from high pet ownership rates combined with extensive pet insurance coverage, which drives demand for advanced diagnostic solutions. The region’s healthcare infrastructure, supported by progressive regulatory frameworks like those enforced by the U.S. Food and Drug Administration (FDA), ensures timely approval and adoption of innovative diagnostic technologies. Additionally, leading companies such as IDEXX Laboratories have bolstered market growth by enhancing diagnostic accuracy through cutting-edge tools. Consumer preference for preventative and personalized veterinary care also contributes to this robust demand. With sustained investments in research and digital veterinary platforms, North America continues to be a critical hub for technological advancements and service delivery in infectious disease diagnostics, presenting significant opportunities for stakeholders aiming to capitalize on a mature yet evolving market landscape.
The United States anchors the North American veterinary infectious disease diagnostics market, driven by widespread pet ownership and sophisticated insurance ecosystems covering veterinary services. Regulatory agencies like the USDA’s Center for Veterinary Biologics play a pivotal role in facilitating the development and commercialization of diagnostic tests, enhancing market confidence. Major players such as Zoetis leverage these dynamics by expanding their diagnostic portfolios and engaging veterinary professionals through targeted educational programs, reflecting the country’s strong emphasis on veterinary health. This strategic environment not only supports continuous innovation but also amplifies demand for early and accurate infectious disease detection, reinforcing the U.S. as the cornerstone of the region’s market trajectory and a gateway for introducing novel diagnostic modalities.
Asia Pacific Market Analysis:
Asia Pacific emerged as the fastest-growing region in the veterinary infectious disease diagnostics market, registering a robust CAGR of 11.04%. This rapid growth is primarily driven by the expanding livestock populations and strengthening veterinary infrastructure across the region. Countries in Asia Pacific are witnessing heightened demand for advanced diagnostics solutions, propelled by rising consumer awareness of animal health and safety, particularly in response to zoonotic disease risks. Investments in veterinary healthcare facilities and technological modernization are also fostering the adoption of cutting-edge diagnostic tools, as seen in recent policy support from the Food and Agriculture Organization (FAO) of the United Nations encouraging sustainable livestock farming practices. The region’s diverse agricultural landscape, coupled with increasing government collaborations and private sector innovations, positions Asia Pacific as a critical hub for market expansion in veterinary infectious disease diagnostics.
Japan plays a pivotal role in Asia Pacific’s veterinary infectious disease diagnostics market due to its robust veterinary infrastructure and stringent regulatory frameworks that promote high standards in animal health monitoring. Japan’s emphasis on precision diagnostics and biosecurity measures, supported by organizations like the Ministry of Agriculture, Forestry and Fisheries (MAFF), enhances disease control efficacy and diagnostics accuracy. Meanwhile, China’s rapidly expanding livestock sector, underpinned by government initiatives such as the National Animal Disease Prevention and Control Plan, fuels significant demand for comprehensive diagnostic services. China also benefits from increasing adoption of digital and automated diagnostic technologies by leading companies like BGI Group, augmenting the region’s growth potential. Together, Japan’s regulatory rigor and China’s scalable market size reinforce Asia Pacific’s leadership and strategic opportunities within the veterinary infectious disease diagnostics market.
Europe Market Trends:
Europe held a substantial share in the veterinary infectious disease diagnostics market, driven by its well-established animal healthcare infrastructure and increasing investments in advanced diagnostic technologies. The region’s stringent regulatory environment, as overseen by the European Medicines Agency, ensures high standards for diagnostic accuracy and safety, fueling demand for innovative solutions. Growing awareness around animal welfare and food safety has shifted consumer preferences toward early and precise detection of infectious diseases in livestock and companion animals. Additionally, Europe's focus on sustainable agriculture, coupled with digital transformation initiatives across the veterinary sector, supports the integration of rapid, point-of-care diagnostics. Recent corporate advancements, such as IDEXX Laboratories expanding its diagnostic services in key European countries, exemplify the competitive intensity fostering innovation. These dynamics collectively position Europe to capitalize on emerging opportunities by blending technological sophistication with regulatory compliance and market readiness.
Germany plays a critical role within the veterinary infectious disease diagnostics market in Europe, propelled by its robust R&D ecosystem and strong regulatory frameworks. The country’s agricultural emphasis on both intensive and organic livestock farming drives demand for high-precision diagnostic tools to curtail disease outbreaks, as highlighted by the Federal Ministry of Food and Agriculture’s recent initiatives promoting biosecurity. Furthermore, German veterinary diagnostic companies, such as Bio-Rad Laboratories, are at the forefront of introducing cutting-edge molecular diagnostics, reflecting the country’s innovative capabilities. This landscape encourages strategic collaborations between public institutions and private players, accelerating market penetration for novel diagnostic solutions. Germany’s leadership in research and regulation directly supports Europe’s broader potential for delivering advanced, reliable veterinary infectious disease diagnostics underpinned by scientific excellence and operational resilience.
France represents a vital market in Europe’s veterinary infectious disease diagnostics landscape, characterized by a growing emphasis on livestock health management and disease surveillance programs. The French government, through agencies like the French Agency for Food, Environmental and Occupational Health & Safety (ANSES), reinforces disease prevention frameworks, fostering adoption of sophisticated diagnostics across the livestock sector. Consumer demand in France increasingly favors transparency and traceability, strengthening veterinary practices that utilize rapid diagnostic tools for pathogen detection. A notable example includes Vetoquinol’s recent expansion of diagnostic product lines tailored for infectious disease detection in companion animals, illustrating innovation driven by local expertise. France’s integration of policy support with evolving clinical practices enhances Europe’s collective capacity to address infectious disease challenges, underscoring its strategic importance within the regional veterinary diagnostics market.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Segment Leadership and Growth Trends
Veterinary Infectious Disease Diagnostics Market Share (%), Animal Type, 2025
Go beyond the chart, access full insights & data tables
Request Free Sample ReportCompanion animals represented the largest share in the veterinary infectious disease diagnostics market in 2025, propelled by rising pet ownership and increased spending on preventive healthcare and diagnostic testing. This segment leads as pet owners increasingly prioritize early disease detection and wellness, driven by the humanization of pets and a growing awareness of zoonotic risks. The trend aligns with demographic shifts toward urbanization and smaller family units favoring companion animals, which has spurred demand for sophisticated diagnostics. For example, Zoetis and IDEXX Laboratories have reported expanding portfolios and service capabilities targeted at companion animal diagnostics. This segment offers strategic advantages by fostering innovation in point-of-care solutions and personalized veterinary care. Given continuous growth in pet populations and evolving consumer expectations, companion animal diagnostics are poised to remain critical for market participants focusing on enhanced disease management and diagnostic precision.
Analysis by Technology
Immunodiagnostics held the largest share in the veterinary infectious disease diagnostics market in 2025, driven by the affordability, rapid turnaround, and broad adoption of tests such as ELISA and lateral flow assays. The segment’s leadership is rooted in its suitability for diverse diagnostic settings, from reference labs to field applications, supporting timely decision-making. Widespread use by veterinary service providers is reinforced by technological enhancements and streamlined supply chains enabling lower costs and faster delivery, as highlighted by manufacturers like Bio-rad and Thermo Fisher Scientific. Industry adoption continues to expand amid regulatory endorsements recognizing immunoassays’ diagnostic accuracy. This creates growth opportunities for players advancing multiplex platforms and integrated digital reporting tools. Sustained investment in assay development and the need for scalable, user-friendly testing solutions ensure immunodiagnostics will retain prominence in the evolving veterinary diagnostics landscape.
Analysis by End User
Reference laboratories held largest share in the veterinary infectious disease diagnostics market in 2025, underpinned by their advanced infrastructure and capacity for high-complexity testing critical for comprehensive pathogen detection and epidemiological surveillance. Their leadership reflects growing reliance from veterinary clinics and government agencies on centralized, specialized diagnostic services amid increasing regulatory scrutiny and disease outbreak monitoring. Public health authorities like the USDA and OIE underscore the strategic importance of reference labs in controlling veterinary infectious diseases. Advancements in automation, bioinformatics, and sample logistics further reinforce their competitive advantage. The segment presents considerable strategic scope for both established laboratory chains and emerging service providers investing in high-throughput capabilities and integrated data management systems. As disease surveillance demands evolve alongside biosecurity concerns, reference laboratories will remain indispensable within the veterinary infectious disease diagnostics market ecosystem.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Animal Type | Food Producing Animals, Companion Animals | ||
| Technology | Molecular Diagnostics, Immunodiagnostics, Other Technologies | ||
| End User | Veterinary Laboratories and Clinics, Reference Laboratories, Research Institutes and Universities, Point of Care / In House Testing |
Competitive Landscape and Market Positioning
The competitive terrain is shaped by dynamic efforts from these leaders to integrate novel diagnostic platforms and enhance test accuracy and speed. Their collaborations with biotechnology firms and investments in proprietary technologies accelerate pipeline expansion and enable seamless integration into veterinary practices. Strategic acquisitions and partnerships complement organic innovation, allowing swift response to emerging disease threats and evolving regulatory standards. This continuous enhancement solidifies market positioning and intensifies competition. Companies emphasize multiplex assays, point-of-care diagnostics, and comprehensive infectious disease panels, reflecting a commitment to drive precision medicine in veterinary care.
Strategic / Actionable Recommendations for Regional Players
In North America, leveraging strong laboratory networks to introduce integrated diagnostic services aligned with emerging molecular technologies can bolster relevance amidst fierce competition from dominant players. Forming alliances with veterinary clinics and research institutions may enhance adoption of innovative assays tailored to regional disease profiles.
Asian Pacific entities could focus on expanding collaborations with local governments and agribusiness sectors to capture growth in livestock diagnostics, supported by digital platforms and mobile testing solutions to reach underserved rural areas. Prioritizing cost-effective, rapid diagnostics for high-prevalence infections permits effective market penetration against established global players.
European stakeholders may benefit from cultivating cross-border research partnerships emphasizing sustainable animal health and antimicrobial resistance diagnostics to differentiate offerings. Combining advanced biotechnologies with regulatory expertise can facilitate the introduction of next-generation tests, addressing evolving policy and market needs across the region.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| No companies available. | |||||||
Industry Development/News
| Company Name | Date | Key Development |
|---|
Explore This Report
Click a section of the wheel — or its numbered marker — to preview the custom segmentation, custom table of contents, or related reports available for this market.
Veterinary Infectious Disease Diagnostics Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| No segment data available. | |
Veterinary Infectious Disease Diagnostics Market — report.custom
| Custom Chapter | Custom Details | ||
|---|---|---|---|
| No custom TOC data available. | |||
Need a different cut of the data?
Request Custom ResearchHow is the veterinary infectious disease diagnostics industry projected to perform over the next decade?
Which global region commands the highest percentage of the veterinary infectious disease diagnostics market?
Which region leads in terms of year-over-year growth for the veterinary infectious disease diagnostics sector?
Why does companion animals sub-segment dominate the animal type segment of veterinary infectious disease diagnostics sector?
How much is the immunodiagnostics segment expected to grow in the veterinary infectious disease diagnostics industry beyond 2025?
What factors give reference laboratories segment a competitive edge in the veterinary infectious disease diagnostics sector?
What are the key competitors in the veterinary infectious disease diagnostics landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source Category | Research Sources | Purpose |
|---|---|---|
| Government Publications | Government agencies, statistical departments, regulatory bodies | Industry statistics, regulatory insights, and policy analysis |
| Company Disclosures | Annual reports, investor presentations, financial filings | Company performance, business strategy, and market positioning |
| Trade Associations | Industry associations and professional organizations | Industry developments, standards, and market perspectives |
| Technical Literature | Research papers, technical publications, academic journals | Technology developments and technical validation |
| Patent Analysis | Patent databases and intellectual property publications | Innovation trends, technology activity, and competitive research |
| Industry Databases | Established research databases and market intelligence resources | Market benchmarking, historical data, and industry analysis |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization